To investigate the role of ST3GAL4 and ST3GAL3 in PDA malignant progression, we targeted both genes for silencing through shRNA technology in BxPC-3 and Capan-1 cell lines. The gene discussed is ST3GAL4; the disease is Patent ductus arteriosus.